期刊文献+

β-内酰胺酶抑制剂的稳定性与降解反应特性

Stability and degradation characteristics ofβ-lactamase inhibitors
下载PDF
导出
摘要 β-内酰胺酶抑制剂与广谱β-内酰胺抗生素的联合使用是一种有效解决细菌耐药的策略之一。目前上市的β-内酰胺酶抑制剂按其化学结构主要包括氧青霉烯类(克拉维酸)、青霉烷砜类(舒巴坦和他唑巴坦)和二氮杂二环辛烷类化合物(阿维巴坦),本文对临床常见的β-内酰胺酶抑制剂的稳定性与降解反应特性进行综述,并结合当前药典标准中的有关物质检查项,探讨上述β-内酰胺酶抑制剂的杂质谱控制策略。 The combination ofβ-lactamase inhibitors with broad-spectrumβ-lactam antibiotics is one of the effective strategies to meet the challenge of bacterial resistance.Currently,β-lactamase inhibitors mainly used on the market include oxapenems(clavulanic acid),penicillane sulfones(sulbactam and tazobactam)and diazabicyclooctanes(avibactam),according to their chemical structure.In this paper,the stability and degradation mechanisms/characteristics of theβ-lactamase inhibitors were reviewed.Combined with the methods of related substance determination in the specifications of pharmacopeia,the strategy for the impurity profiling control of theβ-lactamase inhibitors was discussed.
作者 胡昌勤 Hu Changqin(National Institutes for Food and Drug Control,Beijing 102629)
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2024年第3期241-251,共11页 Chinese Journal of Antibiotics
关键词 Β-内酰胺酶抑制剂 稳定性 降解反应 杂质谱控制 β-lactamase inhibitor Stability Degradation mechanism Impurity profiling
  • 相关文献

参考文献8

二级参考文献51

  • 1霍秀敏.β-内酰胺类抗生素高分子杂质的研究[J].药品评价,2005,2(5):324-326. 被引量:49
  • 2胡昌勤,金少鸿.β-内酰胺抗生素中的高分子杂质及其分析技术研究进展[J].国外医药(抗生素分册),1996,17(5):336-343. 被引量:45
  • 3童立年.注射用氨苄西林钠舒巴坦钠在常见配伍液中的稳定性考察[J].中国药业,2007,16(10):31-32. 被引量:8
  • 4[1]The State Pharmacopoeia Commission of China.Chinese Pharmacopoeia.(中国药典) [M].1995 Ed.Vol II.Beijing:Chemical Industry Press,1995.740.
  • 5[2]Jorgen L.Determination of water in penicillins using fast Karl Fischer reagents and electronic end-point optimization [J].J Pharm Biomed Anal,1984,2(1):37-41.
  • 6[3]The State Pharmacopoeia Commission of China.Notes of Chinese Pharmacopoeia (中国药典注释) [M].1990 Ed.Vol II.Beijing:Chemical Industry Press,1993.1106.
  • 7Coleman K. Diazabicyclooctanes (DBOs): a potent new class of non-beta-lactam beta-lactamase inhibitors[J]. Current opinion in microbiology, 2011,14 (5): 550.
  • 8Shlaes DM. New beta-lactam-beta-lactamase inhibitor combinations in clinical development[J]. Annals New York Academy Sciences, 2013, 1277: 105.
  • 9张浩元.新型双环β-内酰胺酶抑制剂及二十八烷醇的合成[D].福建:厦门大学,2009.
  • 10Stachyra T, Pechereau MC, BruneauJM, et al. Mechanistic studies of the inactivation of TEM -1 and P99 by NXLl 04, a novel non-beta-lactam beta-lactamase inhibitor[J]. Antimicrobial Agents Chemotherapy, 2010, 54 (12): 5132.

共引文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部